Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Corrigendum to “Effectiveness,safety,and patient-reported outcomes of bictegravir/emtricitabine/tenofovir alafenamide in routine clinical care in Italy: 12-Month results from the BICSTaR cohort”